| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.5 | 0.08 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.08 |